Regenerative Medicine

A High Level of Quality Assurance for Regenerative Medicine and other Related Products

Chiyoda’s technologies, developments, achievements and approach to new projects
  • Construction of a cell processing center (CPC), providing the necessary environment and equipment for culturing and processing cells, pioneering the transition from clinical trials to global commercialization.
  • Design concepts for high-grade aseptic preparation.
  • High level Quality Assurance for regenerative medicinal products

Regenerative medicinal products require a high level of quality assurance for sterile pharmaceuticals. Chiyoda’s expertise in facilities that achieve a high-level of quality assurance for regenerative medicinal products is accrued from our sterile pharmaceutical experience.

CPC: Facilities that provide the environment and equipment necessary to culture and process cells.

Development Outline
The world's first facility dedicated to the commercial manufacture of regenerative medicine and cell therapy products derived from allogenic iPS cells
Development Outline
The World’s first GMP* Compliant Vector Manufacturing Plant with “Sendai Virus Vector”
* Good Manufacturing Practice
Our Business